Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials

Sun, L; Guo, YJ; Song, J; Wang, YR; Zhang, SL; Huang, LT; Zhao, JZ; Jing, W; Han, CB; Ma, JT

Ma, JT (corresponding author), China Med Univ, Shengjing Hosp, Dept Oncol, Shenyang, Peoples R China.

FRONTIERS IN ONCOLOGY, 2021; 10 ():

Abstract

Purpose The role of neoadjuvant epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) targeted therapy for patients with EGFR-mutant......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索